Stock listing
Kalaris Therapeutics, Inc.
Selected listing: KLRS · NASDAQ · USD · US
Kalaris Therapeutics, Inc. (NASDAQ:KLRS), Health Technology. Latest release Aug 31, 2026: Kalaris to Present at Morgan Stanley 24th Annual Global Healthcare…
- Ticker
- NASDAQ:KLRS
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About Kalaris Therapeutics, Inc.
The company focuses on developing innovative therapeutic solutions. Kalaris is committed to advancing healthcare through its research and development efforts.
Latest news from Kalaris Therapeutics, Inc.
Kalaris to Present at Morgan Stanley 24th Annual Global Healthcare Conference
August 31, 2026
Kalaris Expands Leadership Team Appointing Liisa Bayko as Chief Financial Officer
July 20, 2026
Kalaris Therapeutics Reports Positive TH103 Phase 1a SAD Results from Expanded Neovascular AMD Cohorts
July 17, 2026
Kalaris Appoints Laurie Keating to Board of Directors
July 6, 2026
Kalaris Announces Upcoming Presentation of TH103 Phase 1a Clinical Data at American Society of Retina Specialists; Ph 1b/2 Clinical Trial Actively Enrolling
June 22, 2026
Research Kalaris Therapeutics, Inc.
Kalaris Therapeutics, Inc. company profile
View the public company page for Kalaris Therapeutics, Inc. on 6ix.
Kalaris Therapeutics, Inc. news
Read company news and market updates connected to Kalaris Therapeutics, Inc..
Kalaris Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Kalaris Therapeutics, Inc..